Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:56 PM
Ignite Modification Date:
2025-12-24 @ 5:56 PM
NCT ID:
NCT03332368
Eligibility Criteria:
Participants' inclusion criteria are as follows:
1. The primary breast cancer after surgical treatment, the pathological diagnosis of breast epithelial tumors (breast cancer), ER, PR and Her-2 immunohistochemical results were negative;
2. no recurrence of metastasis;
3. card score ≥ 60 points;
4. Female patients aged 18-75 years (including 18,75 years);
5. there is no serious organic or functional disorders, no drugs and food allergy;
6. willing to receive treatment, observation and inspection.
Participants' exclusion criteria are as follow:
1. does not meet the inclusion criteria;
2. patients expected to survive \<6 months;
3. combined with cardiovascular and cerebrovascular, liver, kidney, hematopoietic system of serious primary disease and mental illness;
4. breastfeeding, pregnancy or women preparing for pregnancy;
5. allergies and allergies to a variety of drugs;
6. are participating in other drug subjects.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT03332368
Study Brief:
Protocol Section:
NCT03332368